August 23, 2012
The Ministry of Health, Labor and Welfare (MHLW) plans to issue a notification recommending the use of GlaxoSmithKline K.K.’s (GSK) Parkinson's disease treatment ReQuip CR Tablets 2 mg/8 mg (ropinirole), for which NHI listing was approved at a general assembly...read more